Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin.

The presence of endotoxin from Gram-negative bacteria signals the innate immune system to up-regulate bacterial clearance and/or killing mechanisms. Paradoxically, such responses also contribute to septic shock, a clinical problem occurring with high frequency in Gram-negative septicemia. CD14 is a receptor for endotoxin (lipopolysaccharide, LPS) and is thought to have an essential role in innate immune responses to infection and thereby in the development of septic shock. Using a novel rabbit model of endotoxic shock produced by multiple exposures to endotoxin, we show that anti-rabbit CD14 mAb, which blocks LPS-CD14 binding, protects against organ injury and death even when the antibody is administered after initial exposures to LPS. In contrast, anti-rabbit tumor necrosis factor mAb treatment fails to protect when administered after LPS injections. These results support the concept that anti-CD14 treatment provides a new therapeutic window for the prevention of pathophysiologic changes that result from cumulative exposures to LPS during septic shock in man.

[1]  E. Deitch.  ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.

[2]  Georges E. Grau,et al.  TNF inhibition and sepsis — sounding a cautionary note , 1997, Nature Medicine.

[3]  G. Rune,et al.  Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection , 1997, Nature.

[4]  L. Koniaris,et al.  Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Silver,et al.  Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. , 1996, Immunity.

[6]  L. Kline,et al.  ENDOTOXIN TOLERANCE IS INDUCED IN CHINESE HAMSTER OVARY CELL LINES EXPRESSING HUMAN CD14 , 1996, Shock.

[7]  A. Baue.  Predicting outcome in injured patients and its relationship to circulating cytokines. , 1995, Shock.

[8]  R. Ulevitch,et al.  Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. , 1995, Annual review of immunology.

[9]  S. Goyert,et al.  CD14-deficient mice are exquisitely insensitive to the effects of LPS. , 1995, Progress in clinical and biological research.

[10]  M. Hazinski,et al.  Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. , 1993, American Journal of Critical Care.

[11]  R. Bone,et al.  Gram-negative sepsis. Background, clinical features, and intervention. , 1991, Chest.

[12]  D. Remick,et al.  Sandwich ELISA for detection of picogram quantities of interleukin-8. , 1991, Immunological investigations.

[13]  R. Danner,et al.  Endotoxemia in human septic shock. , 1991, Chest.

[14]  K. Glaser,et al.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. , 1990, The Journal of clinical investigation.

[15]  S. Zuckerman,et al.  Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. , 1989, Circulatory shock.

[16]  J. Harlan,et al.  Production of human tumor necrosis factor from whole blood ex vivo. , 1989, Lymphokine research.

[17]  G. Ramadori,et al.  Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐α , 1988 .

[18]  R. Ulevitch,et al.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.

[19]  H. Buller,et al.  ENDOTOXAEMIA: AN EARLY PREDICTOR OF SEPTICAEMIA IN FEBRILE PATIENTS , 1988, The Lancet.

[20]  T. Espevik,et al.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.

[21]  I. Chaudry,et al.  Sepsis and septic shock--a review of laboratory models and a proposal. , 1980, The Journal of surgical research.

[22]  W. R. Mccabe,et al.  Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients , 1980 .

[23]  A. Michael,et al.  Unilateral Shwartzman reaction: cortical necrosis in one kidney following in vivo perfusion with endotoxin. , 1977, Kidney international.

[24]  S. Wolff,et al.  Gram-Negative-Rod Bacteremia , 1974 .

[25]  H. L. Fairchild.  OUR WORLD IN THE MAKING. , 1926, Science.